Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Methotrexate
•
General Rheumatology
•
Nephrology
At what level of renal impairment do you typically reduce or avoid methotrexate in your rheumatology practice?
Related Questions
How would you approach management of a patient with ESRD on the transplant list who is found to have high titer APS labs (ACL, B2GP1, LAC)?
What is your approach to differentiating RA-ILD from medication toxicity (I.e. from methotrexate)?
What are some important considerations for use of ACE inhibition in scleroderma renal crisis patients who require dialysis?
How would you approach management of retroperitoneal fibrosis causing ureteral compression that has already caused irreversible loss of kidney function?
How would you advise a CKD patient who asks about oral NSAIDs for management of chronic pain if they have a contraindication to taking acetaminophen?
Do you always get a baseline chest xray in patients who will be starting methotrexate?
What is your approach to diagnosing and managing methotrexate-induced alopecia?
Would you add immunosuppression for recurrent calcium kidney stones in a patient with sarcoidosis?
How do you approach prescribing analgesics for osteoarthritis related pain in patients with comorbidities, particularly given new evidence that even acetaminophen is associated with increased risk of GI complications (bleeding, peptic ulcer disease), heart failure and CKD?
Have you utilized JAK inhibitors in patients on dialysis?
